VFA
BVS icon

Virtus Fund Advisers’s Bioventus BVS Stock Holding History

Virtus Fund Advisers’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,525
Closed -$42.1K – 115
2024
Q3 		$42.1K Buy
+3,525
New +$30.5K 0.17% 77

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Virtus Fund Advisers's BVS Position: Q4 2024 in Review

Virtus Fund Advisers sold out of Bioventus (BVS) in Q4 2024, closing a stake of 3,525 shares — an estimated $42.1K sold.

Virtus Fund Advisers first reported a position in BVS in Q3 2024 and held it in 1 quarter. The position peaked at $42.1K in Q3 2024. 151 funds tracked by Wall St. Rank hold BVS as of Q4 2024.

  • Virtus Fund Advisers reported no remaining Bioventus position as of Q4 2024 after selling out during the quarter.
  • Virtus Fund Advisers sold 3,525 Bioventus shares in Q4 2024, an estimated $42.1K.
  • Virtus Fund Advisers first reported a position in Bioventus in Q3 2024 and held it in 1 quarter.
  • Virtus Fund Advisers's Bioventus position peaked at $42.1K in Q3 2024.
  • 151 funds tracked by Wall St. Rank held Bioventus as of Q4 2024.

Based on Virtus Fund Advisers's 13F filing for Q4 2024, filed 14 Feb 2025.